8.85
Goodrx Holdings Inc stock is traded at $8.85, with a volume of 505.16K.
It is up +1.26% in the last 24 hours and up +12.60% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$8.74
Open:
$8.84
24h Volume:
505.16K
Market Cap:
$3.32B
Revenue:
$764.16M
Net Income/Loss:
$-6.59M
P/E Ratio:
351.19
EPS:
0.0252
Net Cash Flow:
$86.50M
1W Performance:
+4.12%
1M Performance:
+12.60%
6M Performance:
+36.36%
1Y Performance:
+29.20%
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Dec-01-22 | Initiated | Citigroup | Buy |
Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-12-22 | Initiated | DA Davidson | Neutral |
Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
Jun-06-22 | Resumed | BofA Securities | Buy |
Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-01-22 | Resumed | Credit Suisse | Neutral |
Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-01-22 | Reiterated | Barclays | Overweight |
Mar-01-22 | Reiterated | BofA Securities | Neutral |
Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
Mar-01-22 | Reiterated | Evercore ISI | Outperform |
Mar-01-22 | Reiterated | Goldman | Buy |
Mar-01-22 | Reiterated | JP Morgan | Underweight |
Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
Mar-01-22 | Reiterated | SVB Leerink | Outperform |
Jan-07-22 | Initiated | Goldman | Buy |
Dec-21-21 | Initiated | Stephens | Overweight |
Dec-02-21 | Initiated | Jefferies | Buy |
Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
May-28-21 | Initiated | Robert W. Baird | Neutral |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Jan-25-21 | Initiated | Guggenheim | Buy |
Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-19-20 | Initiated | Barclays | Equal Weight |
Oct-19-20 | Initiated | BofA Securities | Neutral |
Oct-19-20 | Initiated | Citigroup | Buy |
Oct-19-20 | Initiated | Cowen | Outperform |
Oct-19-20 | Initiated | Credit Suisse | Outperform |
Oct-19-20 | Initiated | Deutsche Bank | Hold |
Oct-19-20 | Initiated | Goldman | Neutral |
Oct-19-20 | Initiated | JP Morgan | Neutral |
Oct-19-20 | Initiated | Morgan Stanley | Overweight |
Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
Oct-19-20 | Initiated | SVB Leerink | Outperform |
Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Swiss National Bank Increases Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Defense World
GDRX (GoodRx Holdings) GF Value - GuruFocus.com
GuruFocus.com
(GDRX) Trading Report - Stock Traders Daily
Stock Traders Daily
Jupiter Asset Management Ltd. Buys Shares of 99,605 GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
MarketBeat
Picton Mahoney Asset Management Purchases New Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
MarketBeat
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):